Noxon

Our product, 3-CP , which has a unique antioxidant property, has been shown to to reduces airway inflammation, airway hyper-responsiveness, and other inflammatory mediators of the lung tissues as was seen in animal models of allergic asthma. Nitroxides have been shown to effectively protect cells, tissues, organs, and whole laboratory animals from radicals-induced damage. Fibrosis a debilitating outcome of lung tissue inflammation due to free radicals, was shown to be attenuated by the use of 3-CP in animal models. The drug is intended for oral administration yet it was also shown to be effective when used in other routs of administration. 3-CP has high margin of toxicity and is less likely to cause side effects.